Friday, November 7, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Chemicals

Kronos Worldwide Shares Plummet Following Disappointing Earnings Report

Robert Sasse by Robert Sasse
November 7, 2025
in Chemicals, Commodities, Earnings
0
Kronos Worldwide Stock
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Kronos Worldwide shares experienced a dramatic sell-off after the titanium dioxide producer released third-quarter results that fell significantly short of market expectations. The stock plummeted more than 11% in after-hours trading as investors reacted to unexpected losses and declining revenue figures.

Financial Performance Deteriorates

The company reported a net loss of $37 million, equivalent to $0.32 per share, for the third quarter of 2025. This represents a stark reversal from the $71.8 million profit recorded during the same period last year. On an adjusted basis, the loss stood at $0.18 per share, substantially worse than the $0.06 loss anticipated by market experts.

Revenue declined to $456.9 million, missing analyst projections of $477.3 million and marking a 6% decrease compared to the third quarter of 2024. The market response was immediate and severe.

Should investors sell immediately? Or is it worth buying Kronos Worldwide?

Market Challenges Weigh on Results

Several factors contributed to the company’s disappointing performance:

  • Average selling prices for titanium dioxide pigments dropped 7% year-over-year
  • Reduced production volumes resulted in approximately $27 million in unabsorbed fixed costs during the quarter
  • The TiO₂ segment reported a $15.3 million loss, compared to a $43.4 million profit in the prior year period
  • Operating income fell to negative $19.2 million
  • EBITDA margin collapsed from $123.3 million to just $0.6 million
  • Capacity utilization declined from 92% to 80%

Additional Pressures Emerge

Beyond challenging market conditions, Kronos Worldwide faced a non-cash tax charge of $19.3 million related to revised tax legislation in Germany. The company also cited ongoing market turbulence driven by geopolitical tensions, U.S. trade policies, and customer inventory management strategies as contributing factors.

The titanium dioxide market shows little indication of near-term recovery, leaving Kronos Worldwide fully exposed to the ongoing industry downturn. Current financial results and investor sentiment provide limited grounds for optimism about an immediate turnaround.

Ad

Kronos Worldwide Stock: Buy or Sell?! New Kronos Worldwide Analysis from November 7 delivers the answer:

The latest Kronos Worldwide figures speak for themselves: Urgent action needed for Kronos Worldwide investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 7.

Kronos Worldwide: Buy or sell? Read more here...

Tags: Kronos Worldwide
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Akebia Therapeutics Stock
Earnings

Akebia Therapeutics Shares Rally on Promising Drug Data

November 7, 2025
Bioatla Inc Stock
Analysis

Impressive Survival Data Sparks Rally for BioAtla Shares

November 7, 2025
Mediaalpha Stock
Banking & Insurance

MediaAlpha Shares Surge on Strong Earnings and Buyback Announcement

November 7, 2025
Next Post
SunCoke Energy Stock

SunCoke Energy Shares Plummet Despite Strong Quarterly Performance

Boeing Stock

Boeing's Survival Battle: Financial Distress Meets Glimmers of Hope

CommScope Stock

CommScope Shares Surge on Blockbuster Earnings and Strategic Transformation

Recommended

Corsair Gaming Stock

Corsair Gaming Shares Approach Critical Juncture Ahead of Earnings

7 days ago
Newmont Mining Stock

Leadership Shifts Reshape Global Gold Mining Sector

1 month ago
Mid-America Apartment Communities Stock

Mid-America Apartment Communities: A Stock at a Critical Juncture

6 days ago

New Minimum Postage Requirement Announcement

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Impressive Survival Data Sparks Rally for BioAtla Shares

Is the High-Dividend Strategy Losing Its Appeal?

MediaAlpha Shares Surge on Strong Earnings and Buyback Announcement

Lyft Shares Extend Gains Following Impressive Q3 2025 Earnings

Gogo’s 5G Aviation Network Gains Momentum Amid Strong Quarterly Performance

TransMedics Stock: Assessing the Path Forward After Strong Earnings

Trending

Equitrans Midstream Stock
Analysis

EQT Advances Major Pipeline Expansion Amid Strong Market Demand

by Felix Baarz
November 7, 2025
0

EQT Corporation is accelerating development of the Mountain Valley Pipeline with a significant increase in its expansion...

Akebia Therapeutics Stock

Akebia Therapeutics Shares Rally on Promising Drug Data

November 7, 2025
First Trust BuyWrite Income ETF Stock

Covered Call Strategies Shine as Market Volatility Intensifies

November 7, 2025
Bioatla Inc Stock

Impressive Survival Data Sparks Rally for BioAtla Shares

November 7, 2025
Vanguard High Dividend Yield Index Fund ETF Shares Stock

Is the High-Dividend Strategy Losing Its Appeal?

November 7, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • EQT Advances Major Pipeline Expansion Amid Strong Market Demand
  • Akebia Therapeutics Shares Rally on Promising Drug Data
  • Covered Call Strategies Shine as Market Volatility Intensifies

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com